[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Page 59645]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24106]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-526]
Bulk Manufacturer of Controlled Substances Application: Noramco
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturer of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 6, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 6, 2019, Noramco Inc., 500 Swedes Landing
Road, Wilmington, Delaware 19801-4417 applied to be registered as a
bulk manufacturer of the following basic classes of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
Codeine-N-oxide......................... 9053 I
Dihydromorphine......................... 9145 I
Hydromorphinol.......................... 9301 I
Morphine-N-oxide........................ 9307 I
Amphetamine............................. 1100 II
Methylphenidate......................... 1724 II
Nabilone................................ 7379 II
Phenylacetone........................... 8501 II
Codeine................................. 9050 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Hydrocodone............................. 9193 II
Morphine................................ 9300 II
Oripavine............................... 9330 II
Thebaine................................ 9333 II
Opium extracts.......................... 9610 II
Opium fluid extract..................... 9620 II
Opium tincture.......................... 9630 II
Opium, powdered......................... 9639 II
Opium, granulated....................... 9640 II
Oxymorphone............................. 9652 II
Noroxymorphone.......................... 9668 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
as an Active Pharmaceutical Ingredient (API) for supply to its
customers. In reference to drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
Dated: October 22, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-24106 Filed 11-4-19; 8:45 am]
BILLING CODE 4410-09-P